These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1376630)

  • 1. Clinical value of measuring the interferon-induced enzyme 2'-5'-oligoadenylate synthetase in children.
    Huppertz HI; Becker K; Kreth HW
    Acta Paediatr; 1992 Apr; 81(4):329-34. PubMed ID: 1376630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
    Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of interferon levels with leukocyte (2'-5') oligoadenylate synthetase activity as markers of viral encephalopathies.
    Kennedy CR; Tilles JG
    J Interferon Res; 1988 Oct; 8(5):609-15. PubMed ID: 2466911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers.
    Sasaki K; Fujita I; Hamasaki Y; Miyazaki S
    J Infect Chemother; 2002 Mar; 8(1):76-80. PubMed ID: 11957124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
    Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
    Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
    Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
    J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.
    Hylton W; Cayley J; Dore C; Denman AM
    Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator?
    Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA
    J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome.
    Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA
    J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
    Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
    Merritt JA; Borden EC; Ball LA
    J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2',5'-Oligoadenylate synthetase activity and T cell subset in the cerebrospinal fluid and peripheral blood of aseptic meningitis.
    Sakatoku H; Inoue M; Kojima M; Azuma E; Komada Y; Zhou YW; Zhang SL; Sakurai M
    Acta Paediatr Jpn; 1997 Feb; 39(1):48-53. PubMed ID: 9124053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
    Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 2',5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C.
    Yang PM; Wang JT; Chiang BL; Lai MY; Chen DS
    J Formos Med Assoc; 1997 May; 96(5):314-9. PubMed ID: 9170817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of 2',5'-oligoadenylate synthetase activity measurement: using whole blood as a highly sensitive method to detect the effects of IFN.
    Uno K; Suginoshita Y; Kakimi K; Moriyasu Y; Nakano K; Nakamura N; Fujita T; Horino Y; Sato T; Kishida T
    J Virol Methods; 2006 Sep; 136(1-2):185-92. PubMed ID: 16828170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.
    Schattner A; Wallach D; Merlin G; Hahn T; Levin S; Ramot B; Revel M
    J Interferon Res; 1982; 2(3):355-61. PubMed ID: 6182252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.